Home

Pro-Dex, Inc. - Common Stock (PDEX)

63.23
+2.13 (3.49%)
NASDAQ · Last Trade: Apr 14th, 3:14 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close61.10
Open61.10
Bid63.01
Ask70.00
Day's Range59.95 - 65.87
52 Week Range16.83 - 65.87
Volume55,528
Market Cap206.20M
PE Ratio (TTM)31.62
EPS (TTM)2.0
Dividend & YieldN/A (N/A)
1 Month Average Volume41,624

Chart

About Pro-Dex, Inc. - Common Stock (PDEX)

Pro-Dex Inc is a company focused on the design, development, and manufacturing of innovative medical devices and precision motion control products. They cater primarily to the healthcare sector, providing cutting-edge solutions that enhance surgical procedures and improve patient outcomes. With a commitment to quality and technological advancement, Pro-Dex works closely with healthcare professionals to ensure that their products meet the evolving needs of the medical community, ultimately aiming to contribute to advancements in patient care and medical practices. Read More

News & Press Releases

Evaluating PRO-DEX INC (NASDAQ:PDEX) for Growth Investment Opportunities.chartmill.com
A fundamental analysis of (NASDAQ:PDEX): PRO-DEX INC (NASDAQ:PDEX) is a candidate for growth investors. Here's why.
Via Chartmill · April 12, 2025
Is PRO-DEX INC (NASDAQ:PDEX) suited for growth investing?chartmill.com
A fundamental analysis of (NASDAQ:PDEX): PRO-DEX INC (NASDAQ:PDEX) is a candidate for growth investors. Here's why.
Via Chartmill · March 21, 2025
Is PRO-DEX INC (NASDAQ:PDEX) suited for growth investing?chartmill.com
A fundamental analysis of (NASDAQ:PDEX): Why PRO-DEX INC (NASDAQ:PDEX) qualifies as a high growth stock.
Via Chartmill · February 28, 2025
PRO-DEX INC (NASDAQ:PDEX) is a candidate for growth investors. Here's why.chartmill.com
A fundamental analysis of (NASDAQ:PDEX): PRO-DEX INC (NASDAQ:PDEX) showing high EPS and FCF growth while beating expectations
Via Chartmill · February 7, 2025
Pro-Dex, Inc. Announces Fiscal 2025 Second Quarter and Six-Month Results
IRVINE, CA / ACCESS Newswire / January 30, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2025 second quarter ended December 31, 2024. The Company also filed its Quarterly Report on Form 10-Q for the second quarter of fiscal year 2025 with the Securities and Exchange Commission today.
Via ACCESS Newswire · January 30, 2025
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devicesinvestors.com
Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level.
Via Investor's Business Daily · January 7, 2025
Pro-Dex, Inc. Announces Fiscal 2024 Fourth Quarter and Full-Year Results
IRVINE, CA / ACCESSWIRE / September 5, 2024 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 fourth quarter and full-year ended June 30, 2024.
Via ACCESSWIRE · September 5, 2024
Pro-Dex's Return On Capital Employed Overviewbenzinga.com
Via Benzinga · February 7, 2023
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · November 1, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 1, 2024
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · October 31, 2024
PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results
IRVINE, CA / ACCESSWIRE / October 31, 2024 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2025 first quarter ended September 30, 2024. The Company also filed its Quarterly Report on Form 10-Q for the first quarter of fiscal year 2025 with the Securities and Exchange Commission today.
Via ACCESSWIRE · October 31, 2024
Starbucks To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Mondaybenzinga.com
Via Benzinga · September 9, 2024
PDEX Stock Earnings: Pro-Dex Misses EPS, Beats Revenue for Q3 2024investorplace.com
PDEX stock results show that Pro-Dex missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2024.
Via InvestorPlace · May 2, 2024
Pro-Dex, Inc. Announces Fiscal 2024 Third Quarter And Nine-Month Results
IRVINE, CA / ACCESSWIRE / May 2, 2024 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 third quarter ended March 31, 2024. The Company also filed its Quarterly Report on Form 10-Q for the third quarter of fiscal year 2024 with the Securities and Exchange Commission today.
Via ACCESSWIRE · May 2, 2024
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · February 8, 2024
Pro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month Results
IRVINE, CA / ACCESSWIRE / February 8, 2024 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2024 second quarter ended December 31, 2023. The Company also filed its Quarterly Report on Form 10-Q for the second quarter of fiscal year 2024 with the Securities and Exchange Commission today.
Via ACCESSWIRE · February 8, 2024
3 Very Undervalued Stocks With Strong Growth Prospectsinvestorplace.com
Although the equities sector saw some impressive gains this year, there’s still time for undervalued stocks with strong growth potential.
Via InvestorPlace · December 17, 2023
Pro-Dex, Inc. Announces Fiscal 2024 First Quarter Results
IRVINE, CA / ACCESSWIRE / November 2, 2023 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 first quarter ended September 30, 2023. The Company also filed its Quarterly Report on Form 10-Q for the first quarter of fiscal year 2024 with the Securities and Exchange Commission today.
Via ACCESSWIRE · November 2, 2023
Pro-Dex, Inc. Discusses 4th Quarter and Year-End Results with The Stock Day Podcast
PHOENIX, AZ / ACCESSWIRE / October 26, 2023 / The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ:PDEX)("the Company"), a company that specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets.
Via ACCESSWIRE · October 26, 2023
Pro-Dex, Inc. Announces Fiscal 2023 Fourth Quarter and Full-Year Results
IRVINE, CA / ACCESSWIRE / October 13, 2023 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2023 fourth quarter and full-year ended June 30, 2023. The Company also filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2023, with the Securities and Exchange Commission ("SEC") today.
Via ACCESSWIRE · October 12, 2023
Pro-Dex, Inc. Discusses Record 3rd Quarter Results with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - June 5, 2023) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a...
Via Newsfile · June 5, 2023
Pro-Dex, Inc. Announces Fiscal 2023 Third Quarter and Nine-Month Results
IRVINE, CA / ACCESSWIRE / May 4, 2023 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2023 third quarter ended March 31, 2023. The Company also filed its Quarterly Report on Form 10-Q for the third quarter of fiscal year 2023 with the Securities and Exchange Commission today.
Via ACCESSWIRE · May 4, 2023
Pro-Dex, Inc. Discusses 2nd Quarter Results and 2023 Growth Strategy with The Stock Day Podcast
Phoenix, Arizona--(Newsfile Corp. - February 14, 2023) - The Stock Day Podcast welcomed Pro-Dex, Inc. (NASDAQ: PDEX) ("the Company"), a...
Via Newsfile · February 14, 2023
Pro-Dex, Inc. Announces Fiscal 2023 Second Quarter and Six-Month Results
IRVINE, CA / ACCESSWIRE / February 2, 2023 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2023 second quarter ended December 31, 2022. The Company also filed its Quarterly Report on Form 10-Q for the second quarter of fiscal year 2023 with the Securities and Exchange Commission today.
Via ACCESSWIRE · February 2, 2023